These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 7917761

  • 1. [Light chain deposition disease].
    Terzani E, Alterini B, Doni M, Lampronti V, Lusini C, Fazzini G.
    Ann Ital Med Int; 1994; 9(2):100-4. PubMed ID: 7917761
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Light chain deposition disease without detectable light chains in serum or urine. Report of a case and review of the literature.
    van Ingen G, van Bronswijk H, Meijer CJ, Stel HV.
    Neth J Med; 1991 Oct; 39(3-4):142-7. PubMed ID: 1791875
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nodular glomerulopathy associated with nonamyloidotic kappa light chain deposits and excess immunoglobulin light chain synthesis.
    Gallo GR, Feiner HD, Katz LA, Feldman GM, Correa EB, Chuba JV, Buxbaum JN.
    Am J Pathol; 1980 Jun; 99(3):621-44. PubMed ID: 6770693
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Systemic light-chain disease as a complication of plasmacytoma].
    Grussendorf M, Grussendorf M, Waldherr R, Seelig HP, Ritz E.
    Dtsch Med Wochenschr; 1984 Sep 14; 109(37):1405-9. PubMed ID: 6434278
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation.
    Weichman K, Dember LM, Prokaeva T, Wright DG, Quillen K, Rosenzweig M, Skinner M, Seldin DC, Sanchorawala V.
    Bone Marrow Transplant; 2006 Sep 14; 38(5):339-43. PubMed ID: 16862166
    [Abstract] [Full Text] [Related]

  • 15. Recurrence of light chain deposit disease after renal allograft transplantation: potential role of rituximab?
    Kuypers DR, Lerut E, Claes K, Evenepoel P, Vanrenterghem Y.
    Transpl Int; 2007 Apr 14; 20(4):381-5. PubMed ID: 17326779
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fibrillary glomerulopathy secondary to light chain deposition disease in a patient with monoclonal gammopathy.
    Sundaram S, Mainali R, Norfolk ER, Shaw JH, Zhang PL.
    Ann Clin Lab Sci; 2007 Apr 14; 37(4):370-4. PubMed ID: 18000296
    [Abstract] [Full Text] [Related]

  • 18. Proliferative glomerulonephritis with discrete deposition of monoclonal immunoglobulin γ1 CH 2 heavy chain and κ light chain: a new variant of monoclonal immunoglobulin deposition disease.
    Komatsuda A, Ohtani H, Sawada K, Joh K, Wakui H.
    Pathol Int; 2013 Jan 14; 63(1):63-7. PubMed ID: 23356227
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.